1-7 of 7
Justin M. Darrah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab, Gemcitabine, and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A Match-Adjusted Comparative Analysis

Javier Munoz, Allison C. Rosenthal, Andrew Ip, Justin M. Darrah, Tongsheng Wang, Guihua Zhang, Alex Mutebi, Monika Jun, Zhijie Ding, Anindit Chhibber, Fernando Rivas Navarro, Malene Risum, Mohammad Atiya, Samantha Brodkin, Anthony W Wang, Abualbishr Alshreef, Diala Harb, Mariana Sacchi, Daniela Hoehn, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 7760.
https://doi.org/10.1182/blood-2024-203876
Published: 2024
Journal Articles

Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Glofitamab or Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A Match-Adjusted Comparative Analysis

Andrew Ip, Javier Munoz, Allison C. Rosenthal, Justin M. Darrah, Tongsheng Wang, Guihua Zhang, Alex Mutebi, Monika Jun, Zhijie Ding, Anindit Chhibber, Fernando Rivas Navarro, Malene Risum, Mohammad Atiya, Samantha Brodkin, Anthony W Wang, Abualbishr Alshreef, Diala Harb, Mariana Sacchi, Daniela Hoehn, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 7757.
https://doi.org/10.1182/blood-2024-203540
Published: 2024
Journal Articles

Comparison of Tacrolimus/Methotrexate and Post-Transplant Cyclophosphamide Graft-Versus Host Disease Prophylaxis for Haploidentical and Matched Allogeneic Stem Cell Transplantation Demonstrates Improved Overall Survival and Reduced Mortality, Shorter Length of Stay, Less Peritransplant Toxicity with Post-Transplant Cyclophosphamide

Noah Merin, Haein Kim, Yuliya Linhares, Akil Merchant, Justin M. Darrah, Joshua Sasine, Hannah Lee, Robert Allen Vescio, David Oveisi, Brittany McGalliard, Ali Rejali, Patricia VanStrien, Ellen B. Klapper, Behrooz Hakimian, John Chute, Ronald Paquette
Journal: Blood
Blood (2024) 144 (Supplement 1): 2104.
https://doi.org/10.1182/blood-2024-202176
Published: 2024
Journal Articles

Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)

Justin M. Darrah, Indumathy Varadarajan, Amitkumar Mehta, Jennifer N. Saultz, Matthew McKinney, Monalisa Ghosh, Usama Gergis, Girish Bende, Siddha Kasar, Bradley Hupf, Sharon Chen, Leopold Sellner, Reem Karmali
Journal: Blood
Blood (2024) 144 (Supplement 1): 95.
https://doi.org/10.1182/blood-2024-194807
Published: 2024
Journal Articles

Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial

Lori A. Leslie, Chan Y. Cheah, Franck Morschhauser, Justin M. Darrah, Joshua Brody, David Belada, Juraj Duras, Joost S.P. Vermaat, Gerardo Musuraca, Kojo Osei-Bonsu, Yi Hao, Kimberly G. Archer, Monica Wielgos-Bonvallet, Ali Rana, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3106.
https://doi.org/10.1182/blood-2024-199652
Published: 2024
Journal Articles

Multiplex Analysis of Peripheral Blood in Cancer Patients Predicts Humoral and Cellular Responses to Sars-Cov-2 Vaccines

Maryam Kazerani, Simeon Mahov, Joslyn Foley, Noah Merin, So Yung Choi, Joseph Lownik, Alexander Xu, Larry Milshteyn, Anton Luis Villamejor, Maimoona Nadri, Nathalie Nguyen, Omid Hamid, Justin M. Darrah, Jun Gong, Ronald Paquette, Alain Mita, Robert Allen Vescio, Inderjit Mehmi, Warren Tourtellotte, V Krishnan Ramanujan, Karen Reckamp, Jane Figueiredo, Akil Merchant
Journal: Blood
Blood (2024) 144 (Supplement 1): 3922.
https://doi.org/10.1182/blood-2024-208261
Published: 2024
Journal Articles

Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial

Joost S.P Vermaat, Joshua Brody, Juraj Ďuraš, Yasmin H. Karimi, Chan Y. Cheah, Justin M. Darrah, Gerardo Musuraca, Franck Morschhauser, Daniela Hoehn, Ali Rana, Yaou Song, Pegah Jafarinasabian, David Belada
Journal: Blood
Blood (2023) 142 (Supplement 1): 4457.
https://doi.org/10.1182/blood-2023-180935
Published: 2023